EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Orexin pathway modulation in narcolepsy: from Autoimmune mechanisms to nanotechnology enabled therapeutic delivery

Muhammad Irfan, Nida Shahid, Ayesha Nasar, Mahnoor Azmat, Fiza Khalid, Samreen Azam

Sleep Medicine · 2026-12 · 148 · 109253

DOI: 10.1016/j.sleep.2026.109253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sleep Medicine, 2026-12. Verfasst von Muhammad Irfan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, Hafiz Hayat Campus, University of Gujrat, Gujrat (50700), Pakistan; Institute of Veterinary Medicine an…. Hauptthemen laut MEDLINE: Narcolepsy, Orexins, Nanotechnology, Drug Delivery Systems. Die Arbeit nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Narcolepsy is a long-term brain disorder caused by disrupted orexin signaling. Orexin neurons sit in the hypothalamus and control the sleep-wake cycle; damage to these neurons leads to narcolepsy. Early evidence pointed to an autoimmune attack on orexin neurons as the main cause. Current treatments - stimulants, antidepressants, sodium oxybate, and scheduled naps - ease symptoms but do not stop the disease, and they often cause side effects such as anxiety, insomnia, and heart problems. Most of these drugs also cannot cross the blood-brain barrier (BBB) to act directly on the hypothalamus. This review examines the autoimmune basis of orexin neuron loss in narcolepsy and looks at how nanotechnology-based delivery systems could carry orexin peptides, genes, or antibodies across the BBB. We highlight priorities for future work: nano-enabled drug delivery, gene and peptide-based therapies, long-term safety data, and treatment approaches tailored to each patient. Progress in this area could shift narcolepsy care from symptom control toward real disease-modifying therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NarcolepsyOrexinsNanotechnologyDrug Delivery SystemsHumansNeuronsAnimalsBlood-Brain BarrierAutoimmunity

Stichwörter der Autor:innen

Auto-immune theoryDrug delivery using nanotechnologyLoss of orexin neuronsNarcolepsyNeuro-therapyPeptide replacement theory

Substanzen

Orexins

Autor:innen und Institutionen

  • Department of Biochemistry and Biotechnology, Hafiz Hayat Campus, University of Gujrat, Gujrat (50700), Pakistan; Institute of Veterinary Medicine and Animal Sciences, Chair of Veterinary Biomedicine and Food Hygiene, E…
  • Department of Biochemistry and Biotechnology, Hafiz Hayat Campus, University of Gujrat, Gujrat (50700), Pakistan.
  • Department of Biochemistry and Biotechnology, Hafiz Hayat Campus, University of Gujrat, Gujrat (50700), Pakistan. Electronic address: 23011560-009@uog.edu.pk.

Zitieren

APA

Irfan, M., Shahid, N., Nasar, A., Azmat, M., Khalid, F., & Azam, S. (2026). Orexin pathway modulation in narcolepsy: from Autoimmune mechanisms to nanotechnology enabled therapeutic delivery. Sleep Medicine, 148, 109253. https://doi.org/10.1016/j.sleep.2026.109253

Vancouver

Irfan M, Shahid N, Nasar A, Azmat M, Khalid F, Azam S. Orexin pathway modulation in narcolepsy: from Autoimmune mechanisms to nanotechnology enabled therapeutic delivery. Sleep Medicine. 2026;148:109253. doi:10.1016/j.sleep.2026.109253

BibTeX
@article{Irfan2026,
  author = {Irfan, Muhammad and Shahid, Nida and Nasar, Ayesha and Azmat, Mahnoor and Khalid, Fiza and Azam, Samreen},
  title = {Orexin pathway modulation in narcolepsy: from Autoimmune mechanisms to nanotechnology enabled therapeutic delivery},
  journal = {Sleep Medicine},
  year = {2026},
  volume = {148},
  pages = {109253},
  doi = {10.1016/j.sleep.2026.109253}
}
Kostenlos starten →